FDA Inspection 1247125 — Intermountain Health Saint Joseph Hospital
The FDA completed an inspection of Intermountain Health Saint Joseph Hospital on Aug 5, 2024 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Denver, CO (United States)